Evidence map›Paper›PMID 19562077›Full record

ArticlePloS one2009

Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes.

Isabel Rubio-Aliaga, Gerhard K H Przemeck, Helmut Fuchs, Valérie Gailus-Durner, Thure Adler, Wolfgang Hans, Marion Horsch, Birgit Rathkolb, Jan Rozman, Anja Schrewe and 11 more

Abstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Frontiers in neuroscience · 2022
    Article
  3. Biological Significance of NOTCH Signaling Strength.Frontiers in cell and developmental biology · 2021
    Review
  4. Review
  5. Article
  6. Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation.Laboratory investigation; a journal of technical methods and pathology · 2016
    Article
  7. Article
  8. Article
  9. Review
  10. Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.Circulation journal : official journal of the Japanese Circulation Society · 2013
    Review
  11. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Isabel Rubio-AliagaInstitute of Experimental Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany.
Gerhard K H Przemeck
Helmut Fuchs
Valérie Gailus-Durner
Thure Adler
Wolfgang Hans
Marion Horsch
Birgit Rathkolb
Jan Rozman
Anja Schrewe
Sibylle Wagner
Sabine M Hoelter
Lore Becker
Thomas Klopstock
Wolfgang Wurst
Eckhard Wolf
Martin Klingenspor
Boris T Ivandic
Dirk H Busch
Johannes Beckers
Martin Hrabé de Angelis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Notch signaling pathway is an evolutionary conserved signal transduction pathway involved in embryonic patterning and regulation of cell fates during development and self-renewal. Recent studies have demonstrated that this pathway is integral to a complex system of interactions, involving as well other signal transduction pathways, and implicated in distinct human diseases. Delta-like 1 (Dll1) is one of the known ligands of the Notch receptors. The role of the Notch ligands is less well understood. Loss-of-function of Dll1 leads to embryonic lethality, but reduction of Delta-like 1 protein levels has not been studied in adult stage. METHODOLOGY/PRINCIPAL

findingsHere we present the haploinsufficient phenotype of Dll1 and a missense mutant Dll1 allele (Dll1(C413Y)). Haploinsufficiency leads to a complex phenotype with several biological processes altered. These alterations reveal the importance of Dll1 mainly in metabolism, energy balance and in immunology. The animals are smaller, lighter, with altered fat to lean ratio and have increased blood pressure and a slight bradycardia. The animals have reduced cholesterol and triglyceride levels in blood. At the immunological level a subtle phenotype is observed due to the effect and fine-tuning of the signaling network at the different levels of differentiation, proliferation and function of lymphocytes. Moreover, the importance of the proteolytic regulation of the Notch signaling network emphasized. CONCLUSIONS/SIGNIFICANCE: In conclusion, slight alterations in one player of Notch signaling alter the entire organism, emphasizing the fine-tuning character of this pathway in a high number of processes.

Indexed as

AllelesAmino Acid SequenceAnimalsCalcium-Binding ProteinsFemaleIntercellular Signaling Peptides and ProteinsLigandsLymphocytesMaleMiceMice, Inbred C3HModels, BiologicalModels, GeneticMolecular Sequence DataMutationReceptors, NotchCalcium-Binding ProteinsDlk1 protein, mouseIntercellular Signaling Peptides and ProteinsLigandsReceptors, Notch

Identifiers

PMID19562077
PMCPMC2699037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.